Oxygen-insensitive enzymatic reduction of oximes to imines.
暂无分享,去创建一个
B. Clement | Bernd Clement | U. Girreser | Sabine Heberling | Ulrich Girreser | Stephanie Wolf | S. Heberling | S. Wolf
[1] F. Kadlubar,et al. Properties of a NADH-dependent N-hydroxy amine reductase isolated from pig liver microsomes. , 1974, Archives of biochemistry and biophysics.
[2] H. Hucker,et al. Phenylacetone oxime--an intermediate in the oxidative deamination of amphetamine. , 1971, Biochemical pharmacology.
[3] B. Hollis,et al. CYP3A4 is a Human Microsomal Vitamin D 25‐Hydroxylase , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[4] Y. Hofmann,et al. CHARACTERIZATION AND PARTIAL PURIFICATION OF THE RAT AND HUMAN ENZYME SYSTEMS ACTIVE IN THE REDUCTION OF N-HYDROXYMELAGATRAN AND BENZAMIDOXIME , 2005, Drug Metabolism and Disposition.
[5] J. Gorrod,et al. Metabolic N-hydroxylation of substituted acetophenone imines. I. Evidence for formation of isomeric oximes. , 1986, Xenobiotica; the fate of foreign compounds in biological systems.
[6] B. Clement,et al. Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes. , 2005, Life sciences.
[7] S. Spielberg,et al. N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes. , 1995, Drug metabolism and disposition: the biological fate of chemicals.
[8] D W Nebert,et al. Correlation of type I, type II, and reverse type I difference spectra with absolute changes in spin state of hepatic microsomal cytochrome P-450 iron from five mammalian species. , 1978, The Journal of biological chemistry.
[9] B. Testa. Biochemistry of redox reactions , 1995 .
[10] J. Groves,et al. Models of Nitric Oxide Synthase: Iron(III) Porphyrin-Catalyzed Oxidation of Fluorenone Oxime to Nitric Oxide and Fluorenone , 1999 .
[11] B. Clement. REDUCTION OF N-HYDROXYLATED COMPOUNDS: AMIDOXIMES (N-HYDROXYAMIDINES) AS PRO-DRUGS OF AMIDINES , 2002, Drug metabolism reviews.
[12] D. S. Beattie. Enzyme localization in the inner and outer membranes of rat liver mitochondria. , 1968, Biochemical and biophysical research communications.
[13] Jeffrey B. Cheng,et al. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[14] K. Bodin,et al. Metabolism of 25-hydroxyvitamin D3 by microsomal and mitochondrial vitamin D3 25-hydroxylases (CYP2D25 and CYP27A1): a novel reaction by CYP27A1. , 2003, Biochimica et biophysica acta.
[15] C. Hauser,et al. Formation of Certain Mesityl Ketoximes from Ketimines. Beckmann Rearrangements1 , 1955 .
[16] B. Clement,et al. HEPATIC, EXTRAHEPATIC, MICROSOMAL, AND MITOCHONDRIAL ACTIVATION OF THE N-HYDROXYLATED PRODRUGS BENZAMIDOXIME, GUANOXABENZ, AND RO 48-3656 ([[1-[(2S)-2-[[4-[(HYDROXYAMINO)IMINOMETHYL]BENZOYL]AMINO]-1-OXOPROPYL]-4-PIPERIDINYL]OXY]-ACETIC ACID) , 2005, Drug Metabolism and Disposition.
[17] J. Cashman,et al. Detoxication of tyramine by the flavin-containing monooxygenase: stereoselective formation of the trans oxime. , 1997, Chemical research in toxicology.
[18] R. Mcmahon,et al. The mechanism of the oxidation of d-amphetamine by rabbit liver oxygenase. Oxygen-18 studies. , 1971, Biochemical and biophysical research communications.
[19] D. Stiff,et al. Reductive metabolism of the anticonvulsant agent zonisamide, a 1,2-benzisoxazole derivative. , 1992, Xenobiotica; the fate of foreign compounds in biological systems.
[20] S. Ohmori,et al. Rat liver microsomal cytochrome P-450 responsible for reductive metabolism of zonisamide. , 1993, Drug metabolism and disposition: the biological fate of chemicals.
[21] J. Schenkman,et al. The many roles of cytochrome b5. , 2003, Pharmacology & therapeutics.
[22] D. Hainzl,et al. Metabolism of 10,11-dihydro-10-hydroxyimino-5H-dibenz/b, ƒ /azepine-5-carboxamide, a potent anti-epileptic drug , 2002, Xenobiotica; the fate of foreign compounds in biological systems.
[23] L. Trepanier,et al. NADH Cytochrome b5 Reductase and Cytochrome b5 Catalyze the Microsomal Reduction of Xenobiotic Hydroxylamines and Amidoximes in Humans , 2004, Journal of Pharmacology and Experimental Therapeutics.
[24] R. Mcmahon,et al. The enzymatic N-hydroxylation of an imine. A new cytochrome P-450-dependent reaction catalyzed by hepatic microsomal monooxygenases. , 1971, The Journal of biological chemistry.
[25] B. Clement,et al. Microsomal catalyzed N-hydroxylation of guanabenz and reduction of the N-hydroxylated metabolite: characterization of the two reactions and genotoxic potential of guanoxabenz. , 1996, Chemical Research in Toxicology.
[26] B. Clement,et al. Characterization of in vitro biotransformation of new, orally active, direct thrombin inhibitor ximelagatran, an amidoxime and ester prodrug. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[27] K. Mihara. Structure and regulation of rat liver microsomal stearoyl-CoA desaturase gene. , 1990, Journal of biochemistry.
[28] K. Mihara,et al. [9] Detergent-solubilized NADH-cytochrome b5 reductase , 1978 .
[29] J. Boucher,et al. Dehydration of alkyl- and arylaldoximes as a new cytochrome P450-catalyzed reaction: mechanism and stereochemical characteristics. , 1994, Biochemistry.
[30] F. Tiemann. Ueber die Einwirkung von Hydroxylamin auf Nitrile , 1884 .
[31] Y. Yasukochi,et al. Some properties of a detergent-solubilized NADPH-cytochrome c(cytochrome P-450) reductase purified by biospecific affinity chromatography. , 1976, The Journal of biological chemistry.
[32] Kou-Chang Liu,et al. A particularly convenient preparation of benzohydroximinoyl chlorides (nitrile oxide precursors) , 1980 .
[33] M. Schultze-Mosgau,et al. Cytochrome P450 dependent N-hydroxylation of a guanidine (debrisoquine), microsomal catalysed reduction and further oxidation of the N-hydroxy-guanidine metabolite to the urea derivative. Similarity with the oxidation of arginine to citrulline and nitric oxide. , 1993, Biochemical pharmacology.
[34] T. Omura,et al. THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.
[35] L. K.‐C.,et al. ベンゾヒドロキシイミノイルクロリド(ニトリルオキシド前駆体)の非常に便利な製造 , 1980 .
[36] J. Ley,et al. Hydroxy- or methoxy-substituted benzaldoximes and benzaldehyde-O-alkyloximes as tyrosinase inhibitors. , 2001, Bioorganic & medicinal chemistry.
[37] A. Gangloff,et al. Synthesis of 3,5-disubstituted-1,2,4-oxadiazoles using tetrabutylammonium fluoride as a mild and efficient catalyst , 2001 .
[38] C. Y. Huang. Determination of binding stoichiometry by the continuous variation method: the Job plot. , 1982, Methods in enzymology.
[39] K. S. Rogers,et al. Localization of L-lactate dehydrogenase in mitochondria. , 1986, Archives of biochemistry and biophysics.
[40] J. Cashman,et al. N-oxygenation of primary amines and hydroxylamines and retroreduction of hydroxylamines by adult human liver microsomes and adult human flavin-containing monooxygenase 3. , 1996, Chemical research in toxicology.
[41] J. Hauptmann,et al. Reduction of a benzamidoxime derivative to the corresponding benzamidine in vivo and in vitro. , 1988, Die Pharmazie.
[42] R. Estabrook,et al. The measurement of difference spectra: application to the cytochromes of microsomes. , 1978, Methods in enzymology.
[43] B. Clement,et al. Isolation and Characterization of the Protein Components of the Liver Microsomal O2-insensitive NADH-Benzamidoxime Reductase* , 1997, The Journal of Biological Chemistry.
[44] L. Trepanier,et al. NADH-dependent reduction of sulphamethoxazole hydroxylamine in dog and human liver microsomes , 2000, Xenobiotica; the fate of foreign compounds in biological systems.
[45] S. Kamachi,et al. Metabolic activation of 1 α-hydroxyvitamin D 3 in human liver microsomes , 2001 .
[46] S. Ohmori,et al. Characterization of human liver microsomal cytochrome P450 involved in the reductive metabolism of zonisamide. , 1993, Molecular pharmacology.
[47] L. Trepanier,et al. UNUSUAL DEHYDROXYLATION OF ANTIMICROBIAL AMIDOXIME PRODRUGS BY CYTOCHROME b5 AND NADH CYTOCHROME b5 REDUCTASE , 2005, Drug Metabolism and Disposition.
[48] S. Ohmori,et al. Formation of 2-sulphamoylacetylphenol from zonisamide under aerobic conditions in rat liver microsomes. , 1996, Xenobiotica; the fate of foreign compounds in biological systems.
[49] M. Ishigai,et al. Oxime-metabolizing activity of liver aldehyde oxidase. , 1987, Archives of biochemistry and biophysics.
[50] E. Ball,et al. A Hemochromogen Component of Liver Microsomes. , 1952, Proceedings of the National Academy of Sciences of the United States of America.
[51] P. Kruger. Ueber Abkömmlinge des Benzenylamidoxims , 1885 .
[52] J. Boucher,et al. N-hydroxyguanidines as new heme ligands: UV-visible, EPR, and resonance Raman studies of the interaction of various compounds bearing a C=NOH function with microperoxidase-8. , 2001, Biochemistry.
[53] M. Zimmermann,et al. Enzymatic Reduction of Benzamidoxime to Benzamidoxine , 1988, Archiv der Pharmazie.
[54] P. L. Pickard,et al. An Improved Method of Ketimine Synthesis , 1961 .
[55] A. Cederbaum,et al. Interaction of ferric complexes with NADH-cytochrome b5 reductase and cytochrome b5: lipid peroxidation, H2O2 generation, and ferric reduction. , 1996, Archives of biochemistry and biophysics.
[56] B. Judkins,et al. A versatile synthesis of amidines from nitriles via amidoximes , 1996 .